German Build Pharmaceutical Plant Rp1 Trillion Worth

Germany will build a pharmaceutical factory in Indonesia with an investment of Rp 1 trillion (100 million U.S. dollars), because the pharmaceutical industry prospects are quite bright with the large number of residents supported.
“The pharmaceutical plant will produce intravenous fluids and injectable medications that are built in two phases to be completed within the next two years,” said President Director of PT B Braun Medical Indonesia Manogaran in Jakarta on Friday.
Menuru him, at the initial phase of the plant which was built in an area of ​​19 hectares that will have a production capacity of 75 million units per year, and 150 million units in the second phase.
“The pharmaceutical industry in the country is currently growing, because the construction of the plant in order to meet the needs of the wider community is considered very precise. Presence factory We are optimistic that the market will respond well,” he said.
Asked about the investment fund, he said, the fund 100 percent of the B. Braun instead of loans.
“We have the funds to invest in Indonesia,” he said.
Manogaran said, 75 million units of production was around 50 million to meet the needs of domestic and 25 million more for export.
“In the second phase of 150 million units, about 75 million units for export to other countries such as neighbor and Europe,” he said.
He added that the first operational employed about 500 people and will increase up to 800 people at the second stage.
“We will make Jakarta as a training center to prepare an integrated Indonesian experts to contribute in the factories B Braun. We also expect the presence of this plant will be more beneficial to the community especially the Asia Pacific Indonesia can enjoy better health services and affordable, “he said.
Meanwhile, the Board of Director Melsunger B Braun AG, Dr. Meinrad Lugan said, as the pharmaceutical and medical device company that has been supporting the hospital and healthcare industry in the world B Braun continues to innovate to provide products products affordable world-class standards.
“Given the strategic development of Indonesia, the German company committed to make Indonesia as a Center of Excellence for the Asia Pacific region,” he said.
He said, B Braun wanted to help reduce the risk of airborne contamination, bacteria and on bacteria, because it is made of fluid infusion which is the main product used as a basis for patient care.
“For the design of the bottle and technology is an important aspect in addition to the content to be packaged better,” he said.
Advisor to the Minister of Finance and Community Development Division Ministry of Health, Dr Yusharman said investment in the pharmaceutical industry today dalama country desperately needed.
“Because it’s a plan B Braun to build a pharmaceutical factory in Indonesia immediately supported,” he said.
The Government, he added very grateful for the investment made by the German pharmaceutical company.
“Because of his presence will provide support for the need for intravenous fluids is necessary to program the Social Security Agency (BPJS),” he said.
According to him, the Indonesian market in 2013 will require intravenous fluids as much as 100 million units per year and in 2020 will increase to 200 million units per year.
“B Braun also has a research and development center sharing, as well as to educate the Indonesian public, it makes me more optimistic,” he said.

Analysis of stock market investors fear

JAKARTA – Capital market analysts, Pardomuan Sihombing said that the decision of the judges of Corruption (Corruption) in a case of IM2, causing fears of capital market investors. Because the regulations are not clear can ensnare anyone who is doing business in Indonesia.

“It could happen (investors will fear) that the decision was negative, meaning that is associated with the regulation of the telecommunications industry,” said Pardomuan Sihombing, told reporters on Friday (19/7).

It is said, that investors will invest into doubt whether the investment fund to be back or not, when the company suddenly entangled case. Doubt it, he added, is very clearly threatens the entire industry.

“Investors need legal certainty, because that’s what makes the industry rules become clear, so as to ensure the development of the telecommunications industry,” he said.

Pardomuan added that the symptoms have not been perceived concerns, the article of the legal process is not over. However, if there is already a binding verdict and declared IM2 guilty, then the impact will be felt.

“We all expect the final result will be better,” said Pardomuan.

As information, on Monday (8/7) Corruption Court sentenced former Director of IM2, Indar Atmanto to 4 years imprisonment with a fine of Rp200 million with subsidiary imprisonment of 3 months. Judge fines also punish IM2 pay Rp1, 3 trillion. Judges-network cooperation Indosat IM2 there are elements of corruption.

This ruling a major impact, as almost all sectors of the telecommunications businesses registered as a public company is also running a similar business model. Including PT Indosat Tbk, PT Telkomsel, PT XL Axiata Tbk, PT Smartfren Telecom, PT Bakrie Telecom Tbk and other telecommunications operators.

In fact, the communication sector alone contributes to Rp11, 8 trillion in revenues and in 2012. This figure is the biggest revenue for Indonesia in addition to the energy and mineral resources.

Responding to the verdict, Indonesian Infocom Society (Mastel) and the Indonesian Telecommunications Regulatory Body (BRTI) have reported the presiding judge to the Judicial Commission.

Mastel judge there are allegations of violations of the code of conduct by the presiding judge in the case. “There are some points that filed a complaint to the Judicial Commission, namely that the judges in check and try not professional in understanding the case filed,” said Mastel Chairman, Setyanto P. Santosa.

Setyanto judging, the judges are not being fair in making its decision. According to him, the judges only listen to experts from the Public Prosecutor (PP). and ignore the official opinion of the Ministry of Communications and Information Technology as the regulator Telekomunikasi Indonesia.